Dylan Scott, a senior correspondent and editor for Vox, delves into the concerning rise of cancer among younger individuals. The conversation highlights new blood tests like the FDA-approved Shield Blood Test, which promises improved early detection. Scott discusses how lifestyle factors, including processed diets and environmental pollutants, contribute to this alarming trend. He advocates for a shift in screening practices and emphasizes the need to address broader societal factors, rather than just individual choices, in combating cancer.
Younger individuals are experiencing a worrisome rise in colorectal cancer diagnoses, prompting discussions about revising screening age recommendations.
Innovative testing methods like the Shield Blood Test offer a less invasive alternative for detecting colorectal cancer but are less effective for early-stage detection.
Deep dives
Understanding Colonoscopy and Its Preparation
Colonoscopy is a critical screening method for detecting colorectal cancer, recommended to start at age 45. The preparation for this procedure can be quite uncomfortable, requiring individuals to follow a strict cleansing diet and possibly ingest an oral laxative. During the procedure, a doctor uses a telescope-like instrument to examine the colon for any abnormal growths that could indicate cancer. Despite its invasiveness and discomfort, colonoscopy remains the most accurate detection method currently available.
Emergence of a New Blood Test
A new blood test, known as the Shield Blood Test, has been approved by the FDA as an innovative approach to detecting colorectal cancer. This test identifies the genetic signatures of tumors in the bloodstream, making it particularly effective in diagnosing advanced cancers, with nearly 90% accuracy. However, it still falls short in detecting early-stage cancers as compared to traditional methods like colonoscopy. The interest in this blood test stems from its potential to serve as a less intimidating alternative to invasive procedures, which could encourage more people to seek screening.
Rising Incidence of Early-Onset Cancer
Over the past decade, there has been a significant increase in colorectal cancer diagnoses among individuals under 50, raising alarms within the medical community. Recent statistics show that one in five new colorectal cancer cases in the U.S. affects those under 55, a doubling since 1995. While the reasons for this surge remain unclear, potential contributing factors include unhealthy dietary habits, increased obesity rates, and environmental exposures. The challenge lies in the fact that younger individuals often do not receive regular screenings, leading to higher mortality rates in this demographic compared to older patients.
The age when you need to start being screened for cancers may need to be updated, as rates among younger people are on the rise. New testing methods could make the process a lot easier than, say, a colonoscopy - but they’re not perfect.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Public.com+Public Investing: All investing involves risk. Brokerage services for US listed securities, options and bonds in a self-directed brokerage account are offered by Public Investing, member FINRA & SIPC. Not investment advice. Public Investing offers a High-Yield Cash Account where funds from this account are automatically deposited into partner banks where they earn interest and are eligible for FDIC insurance; Public Investing is not a bank.Cryptocurrency trading services are offered by Bakkt Crypto Solutions, LLC (NMLS ID 1828849), which is licensed to engage in virtual currency business activity by the NYSDFS. Cryptocurrency is highly speculative, involves a high degree of risk, and has the potential for loss of the entire amount of an investment. Cryptocurrency holdings are not protected by the FDIC or SIPC. . See public.com/#disclosures-main for more information.